Rockville-based MacroGenics Inc. has struck a drug development deal with Gilead Sciences Inc. that could ultimately be worth $1 billion.
The licensing agreement is for the development and potential commercialization for drugs directed at up to four undisclosed targets.
{iframe}http://www.bizjournals.com/washington/news/2013/01/07/macrogenics-could-get-1b-payday.html?ana=e_du_pap&s=article_du&ed=2013-01-07{/iframe}